An abbreviated MRI protocol is effective in detecting breast cancer and saving resources.
An abbreviated MRI protocol is effective in breast cancer detection and holds promise for resource-efficient breast cancer screening in high-risk women, according to a study published in the journal Academic Radiology. Researchers from Johns Hopkins Medicine in Baltimore, Md., and Columbia University in New York, NY, performed a prospective paired cohort study to assess the performance of an abbreviated MRI protocol as a resource-efficient approach for screening patients at high-risk of breast cancer. It also assesses whether the abbreviated protocol alters the assigned Breast Imaging Reporting and Data System (BI-RADS) category. The researchers reviewed 1,052 MR images of women at high risk of breast cancer using an abbreviated MRI protocol, followed by an immediate review of additional sequences included in a full diagnostic protocol. BI-RADS assessments, including all changes and interpretation time. All were recorded for both the abbreviated and full protocol reviews. Cancer detection rate, positive predictive value 3 (PPV3), sensitivity, and specificity were calculated. The results showed the magnet time for the full protocol was 24 minutes, compared with three minutes with the abbreviated protocol. Cancer detection rate was 13.3 per 1,000 with a PPV3 of 30.4 percent based on the full protocol. Review of sequences included in the full protocol resulted in a change in the final BI-RADS assessments in 3.4 percent of the cases, the majority of which did not change clinical management with respect to biopsy. The sensitivity and specificity of the abbreviated and full protocols were not significantly different. The researchers concluded this pilot study demonstrated effective performance in cancer detection. BI-RADS assessments were rarely altered with the additional information afforded by the full protocol. The abbreviated protocol holds promise for resource-efficient breast cancer screening in high-risk women.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.